Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Japan

Viral Infections, Non-HIV

Potential impact of seasonal forcing on a SARS-CoV-2 pandemic

Swiss Med Wkly.

Neher RA, Dyrdak R, Druelle V, Hodcroft EB, Albert J

doi: 10.4414/smw.2020.20224.

Viral Infections, Non-HIV

Multiplex rt-Real Time PCR assays for diagnostic testing of SARS-CoV-2 and seasonal influenza viruses. A challenge of the phase 3 pandemic setting

J Infect Dis

Mancini F, Barbanti F, Scaturro M, Fontana S, Di Martino A, Marsili G, Puzelli S, Calzoletti L, Facchini M, Di Mario G, Fabiani C, Dstat AB, Riccardo F, Dstat PP, Stefanelli P, Rezza G, Ciervo A

doi: 10.1093/infdis/jiaa658

Viral Infections, Non-HIV

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

Viruses.

Ahmed SF, Quadeer AA, McKay MR

doi: 10.3390/v12030254.

Viral Infections, Non-HIV

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Clin Infect Dis.

Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, Zhan S, Lu R, Li H, Tan W, Liu D

doi: 10.1093/cid/ciaa237.

Viral Infections, Non-HIV

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

N Engl J Med.

van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ

doi: 10.1056/NEJMc2004973.

Viral Infections, Non-HIV

Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals

Nature.

Liu Y, Ning Z, Chen Y, Guo M, Liu Y, Gali NK, Sun L, Duan Y, Cai J, Westerdahl D, Liu X, Xu K, Ho KF, Kan H, Fu Q, Lan K

doi: 10.1038/s41586-020-2271-3.

Viral Infections, Non-HIV

Déjà vu: stimulating open drug discovery for SARS-CoV-2

Drug Discov Today.

Ekins S, Mottin M, Ramos PRPS, Sousa BKP, Neves BJ, Foil DH, Zorn KM, Braga RC, Coffee M, Southan C, Puhl AC, Andrade CH

doi: 10.1016/j.drudis.2020.03.019.

Viral Infections, Non-HIV

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease

Science.

Dai W, Zhang B, Su H, Li J, Zhao Y, Xie X, Jin Z, Liu F, Li C, Li Y, Bai F, Wang H, Cheng X, Cen X, Hu S, Yang X, Wang J, Liu X, Xiao G, Jiang H, Rao Z, Zhang LK, Xu Y, Yang H, Liu H

doi: 10.1126/science.abb4489.

Viral Infections, Non-HIV

Infection of dogs with SARS-CoV-2

Nature.

Sit THC, Brackman CJ, Ip SM, Tam KWS, Law PYT, To EMW, Yu VYT, Sims LD, Tsang DNC, Chu DKW, Perera RAPM, Poon LLM, Peiris M

doi: 10.1038/s41586-020-2334-5.

Related content

Potential impact of seasonal forcing on a SARS-CoV-2 pandemic

Multiplex rt-Real Time PCR assays for diagnostic testing of SARS-CoV-2 and seasonal influenza viruses. A challenge of the phase 3 pandemic setting

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals

Déjà vu: stimulating open drug discovery for SARS-CoV-2

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease

Infection of dogs with SARS-CoV-2